Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Duckworth

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Brain Research. Molecular Brain Research|October 24, 2000
Cloning, localisation and functional expression of a novel human, cerebellum specific, two pore domain potassium channelC G Chapman, H J Meadows, R J Godden, et al.
The Journal of Biological Chemistry|March 29, 2001
Molecular cloning and functional characterization of MCH2, a novel human MCH receptorJ Hill, M Duckworth, P Murdock, et al.
Neuron|February 16, 2006
The HSPGs Syndecan and Dallylike bind the receptor phosphatase LAR and exert distinct effects on synaptic developmentKarl G Johnson, Alan P Tenney, Aurnab Ghose, et al.
Journal of Medicinal Chemistry|December 6, 1996
Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonistsI T Forbes, S Dabbs, D M Duckworth, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2000
1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonistsS M Bromidge, S Davies, D M Duckworth, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2000
1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolytic agentsS M Bromidge, S Dabbs, S Davies, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Model studies on a synthetically facile series of N-substituted phenyl-N'-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT(2C/2B) receptor antagonistsS M Bromidge, S Dabbs, D T Davies, et al.
Journal of Medicinal Chemistry|May 9, 1998
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivoL M Gaster, F E Blaney, S Davies, et al.
Journal of Medicinal Chemistry|May 30, 1998
Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolinesS M Bromidge, S Dabbs, D T Davies, et al.
Operative Neurosurgery (Hagerstown, Md.)|July 3, 2025
Single-Session Middle Meningeal Artery Embolization With Concomitant Evacuation Surgery for Chronic Subdural Hematomas: A Multicenter Assessment of Feasibility, Safety, and EfficacySantiago Gomez-Paz, Kent Richter, Maggie McGrath, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Brain Research. Molecular Brain Research|October 24, 2000
Cloning, localisation and functional expression of a novel human, cerebellum specific, two pore domain potassium channelC G Chapman, H J Meadows, R J Godden, et al.
The Journal of Biological Chemistry|March 29, 2001
Molecular cloning and functional characterization of MCH2, a novel human MCH receptorJ Hill, M Duckworth, P Murdock, et al.
Neuron|February 16, 2006
The HSPGs Syndecan and Dallylike bind the receptor phosphatase LAR and exert distinct effects on synaptic developmentKarl G Johnson, Alan P Tenney, Aurnab Ghose, et al.
Journal of Medicinal Chemistry|December 6, 1996
Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonistsI T Forbes, S Dabbs, D M Duckworth, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2000
1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonistsS M Bromidge, S Davies, D M Duckworth, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2000
1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolytic agentsS M Bromidge, S Dabbs, S Davies, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Model studies on a synthetically facile series of N-substituted phenyl-N'-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT(2C/2B) receptor antagonistsS M Bromidge, S Dabbs, D T Davies, et al.
Journal of Medicinal Chemistry|May 9, 1998
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivoL M Gaster, F E Blaney, S Davies, et al.
Journal of Medicinal Chemistry|May 30, 1998
Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolinesS M Bromidge, S Dabbs, D T Davies, et al.
Operative Neurosurgery (Hagerstown, Md.)|July 3, 2025
Single-Session Middle Meningeal Artery Embolization With Concomitant Evacuation Surgery for Chronic Subdural Hematomas: A Multicenter Assessment of Feasibility, Safety, and EfficacySantiago Gomez-Paz, Kent Richter, Maggie McGrath, et al.
Pageof 12